Gilead Sciences (GILD) Tops Q2 EPS by 41c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Gilead Sciences (GILD) PT Raised to $81 at Deutsche Bank; Light at the End of the Tunnel
July 27, 2017 8:30 AM EDTDeutsche Bank analyst Andrew Peters raised his price target on Gilead Sciences (NASDAQ: GILD) to $81.00 (from $79.00) while maintaining a Buy rating.
Peters commented, "We are reiterating our Buy rating on GILD and establishing a new $81 price target following a strong beat-and-raise quarter which saw... More



